A controversial startup that was charging $8,000 to fill your veins with young blood says it’s halted operations after a warning from regulators

Federal regulators warned people against getting infusions of young blood on Tuesday. Following the warning, a startup called Ambrosia allegedly ceased operations. They'd been charging $8,000 for the procedure despite little hard science.